Capitol Hill Briefs: Device Tax Repeal; Clinical Trials; DME Bidding
This article was originally published in The Gray Sheet
Legislation introduced in the new Republican-controlled Senate include device tax repeal, a measure that would allow Medicaid recipients to enroll in clinical trials and a bill, introduced in parallel in the House, aimed at stopping non-binding bids for supplying durable medical equipment, prosthetics, orthotics and supplies.
You may also be interested in...
AdvaMed says a new Congressional Research Service report underestimates the number of people likely to lose their jobs because of the tax and is looking forward to a new Republican Congress focused on repealing it.
FDA panel unanimously endorses Inspire upper airway stimulator. Stryker buys Berchtold and Pivot. First randomized U.S. study of embolic protection during transcatheter aortic valve replacement approved. More news.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.